Today's Healthcare Pulse
Allogene Therapeutics CEO David Chang to step down
Allogene Therapeutics announced that chief executive David Chang will leave his role. The news was reported by STAT+ and echoed in a follow‑up piece covering broader pharma updates.
Also developing:
By the numbers: Boston Scientific invests $1.5B for 34% stake in MiRus
Travere Therapeutics Reports FDA Full Approval of Filspari for Proteinuria Reduction in FSGS
Travere Therapeutics announced that the U.S. Food and Drug Administration has granted full approval to Filspari (sparsentan) for reducing proteinuria in patients aged eight years and older with focal segmental glomerulosclerosis (FSGS) who do not have nephrotic syndrome. The approval stems from the Phase III DUPLEX trial, which enrolled 371 participants and compared sparsentan to irbesartan. At week 108, sparsentan achieved a 46% reduction in proteinuria versus 30% with irbesartan, with an even larger effect in non‑nephrotic patients. Additionally, sparsentan modestly improved eGFR decline, showing a +1.1 mL/min/1.73 m² difference versus irbesartan.
Google.org and the Johnson & Johnson Foundation Are Launching a $10 Million Initiative to Train Rural U.S. Healthcare Workers in...
Google.org and the Johnson & Johnson Foundation have teamed up to launch a $10 million philanthropic initiative aimed at boosting AI literacy among rural U.S. healthcare workers. Each organization is contributing $5 million to fund training that focuses on foundational AI knowledge,...
Kent Community Health NHS to Procure MSK Physiotherapy AI Service
Kent Community Health NHS Foundation Trust announced plans to procure a UK‑based musculoskeletal (MSK) physiotherapy service powered by artificial intelligence. The hybrid solution will blend AI‑driven triage and assessment with virtual appointments from HCPC‑registered physiotherapists, and must be a Class IIa...
18,000 Lives Later, B.C. Marks 10 Years Since Declaring Overdose Emergency
British Columbia marks a decade since declaring a public‑health overdose emergency, a period that has claimed over 18,000 lives. The province’s death toll rose from 474 in 2015 to more than 2,000 annually before falling to 1,833 in 2025, a...
Daiichi Sankyo and Merck Receives FDA’s Priority Review for Ifinatamab Deruxtecan (I-DXd) to Treat ES-SCLC
Daiichi Sankyo and Merck have secured FDA priority review for ifinatamab deruxtecan (I‑DXd) under the Real‑Time Oncology Review and Project Orbis programs. The decision follows a successful Biologics License Application based on the Phase II IDeate‑Lung01 trial, which enrolled 187 extensive‑stage...
Cody Simmons, DermaSensor
DermaSensor, led by CEO Cody Simmons, has developed a spectroscopy‑based device to detect early skin cancer. Currently only about 8% of individuals with suspicious lesions receive recommended screening, leaving a large gap in early detection. The company is positioning the...
Why Did Resident Doctors Go on Strike and How Much Are They Paid?
Resident doctors in England, who earn roughly $51,000 to $97,000 a year, returned to work after a six‑day, 15th strike over pay and training concerns. The British Medical Association (BMA) argues that despite 33% pay rises since 2023, salaries remain...
Connected Healthcare IoT: Remote Monitoring, Medical Devices and Data Challenges
Connected Healthcare is emerging as a core segment of IoT, linking wearable sensors, implantable devices, and hospital equipment to cloud and edge platforms for real‑time patient monitoring. The architecture relies on multi‑layered connectivity—BLE, Wi‑Fi, LTE‑M, NB‑IoT, and 5G—and data standards...
A Plasma-Based DNA Test for Quantification of Disease Burden in Acute Myeloid Leukemia Patients Undergoing Bone Marrow Transplantation
Researchers at Johns Hopkins introduced a plasma‑based DNA assay, v96, that monitors up to 96 AML‑specific mutations in patients undergoing allogeneic bone‑marrow transplantation. In a cohort of 30 AML patients, the test detected molecular evidence of residual leukemia in 100%...
Finding the Right Five Percent: How Machine Learning Is Reshaping Care Management
Machine learning is being woven into population health programs to move risk stratification from blunt, utilization‑based scores to disease‑centered, predictive analytics. By aggregating claims, labs and medication data into unified clinical profiles, ML models capture nonlinear patterns that linear regressions...
Eli Lilly Reports P-III (BRUIN CLL-322) Trial Data on Jaypirca Combination for CLL/SLL
Eli Lilly announced that its phase‑III BRUIN CLL‑322 trial showed the Jaypirca (pirtobrutinib) + venetoclax + rituximab regimen significantly extended progression‑free survival in relapsed or refractory CLL/SLL compared with venetoclax + rituximab alone. Patients were treated for roughly two years before entering a therapy‑free interval, and the benefit...
Diabetes, Hypertension, and the Rising Health Inequities in Indian Cities
A 2022‑23 qualitative study by the nonprofit SNEHA in a Mumbai‑area municipality reveals that residents of urban informal settlements face severe gaps in non‑communicable disease (NCD) prevention, diagnosis and treatment. Preventive screening is viewed as unaffordable, leading to delayed detection...
Humber Trust to Lead Roll-Out of New NHS App Features
Humber Teaching NHS Foundation Trust has been chosen by NHS England to spearhead the rollout of new Wayfinder‑driven features in the NHS App for 11 other trusts that use the SystmOne electronic patient record. The enhancements will let patients view,...
Demystifying IEC 60601: A Practical Guide for Understanding the IEC 60601 Family Standards
The whitepaper by Element’s Bob Burek breaks down the IEC 60601 family—General, Collateral and Particular standards—into a clear safety framework for medical electrical devices. It stresses the concept of essential performance and mandates ISO 14971 risk management from design through production. The...
The Government Wants to Curb NDIS Spending. Here’s How It Might Succeed
The Australian government plans to curb National Disability Insurance Scheme (NDIS) spending by cutting annual growth from roughly 10% to 5‑6% in the next budget. The scheme now serves about 760,000 people and is projected to cost over A$50 billion (~US$33 billion)...
The Rise and Rise of Icky IVF Ads
UK fertility clinics are flooding public spaces and digital platforms with ads, with a regulator counting 9,340 paid placements on Google and Meta between September 2024 and October 2025. The surge reflects a falling birth rate, NHS austerity that has cut publicly...
Indian States Roll Out Radiology AI and More Briefs
India’s health sector is accelerating AI adoption. Madhya Pradesh has launched a pilot of mlHealth360’s cloud‑based AI radiology platform across ten district hospitals to triage CT scans and speed up diagnosis of strokes, trauma and tumours. Telangana has rolled out...
Mpox Can Infect and Replicate in the Brain, US Health Researchers Say in Fatal HIV Case
U.S. researchers reported that mpox virus replicated in the brain of a 38‑year‑old man with advanced HIV, marking the first documented neuroinvasion of the pathogen. Autopsy findings revealed drug‑resistant viral strains, including mutations linked to reduced efficacy of tecovirimat. The...
Why Home Strep Tests Aren’t Reliable
Pediatrician Dr. Wadie Shabab warns that over‑the‑counter rapid strep kits are unreliable for diagnosing children. Home tests, which use the same antigen‑detection technology as some COVID‑19 kits, often yield false‑negative results and cannot distinguish harmless carriers from active infection. In...
Asking Preadolescents About Suicide Does Not Increase Suicidal Thoughts
Researchers examined whether repeated suicide screening triggers new suicidal thoughts in preadolescents. In a 12‑month longitudinal study of 192 Missouri children aged 8‑12, monthly (low‑risk) or weekly (high‑risk) Ask Suicide‑Screening Questions (ASQ) surveys showed no increase in ideation. Statistical analyses,...
Rollout of Powerful New HIV Prevention Tool in Lower Income Countries Gets a Boost
The U.S. State Department and the Global Fund announced a major scale‑up of Gilead’s long‑acting HIV prevention drug lenacapavir, targeting 3 million people in low‑income countries over the next three years—a 50 % increase from the original 2 million commitment. Lenacapavir, which showed...
Insulin Resistance Is Driving 12 Types of Cancer, Researchers Say
A machine‑learning analysis of the UK Biobank linked insulin resistance to a heightened risk of at least 12 cancer types, with the strongest associations seen for uterine, kidney and esophageal cancers. The study used the HOMA‑IR score as a digital...
Alzheimer's May Be Multifactorial End‑Stage, Not Single Cause
Absolutely astounding that two of the most interesting candidates for lowering Alzheimer’s risk in the last decade came accidentally: GLP-1 drugs and the shingles vaccine. Really suggests Alzheimer’s has no true “cause”, but is the end stage of a long, complex...
AI Threatens Medical Expertise; Recommendations to Prevent Deskilling
In today's @washingtonpost, a terrific piece on the risk of AI-based deskilling in medicine, along with some sensible recommendations. I'm quoted, along with @CarlaPughMDPhD. Authors: Rebecca Adams/Laura Landry. https://t.co/eDlBmNvyXV
Brain Fog Affects Two-Thirds Going Through Menopause
A new Lancet review finds that more than two‑thirds of women experience memory lapses and reduced concentration during the menopause transition, a condition often labeled “brain fog.” The study notes that while these cognitive symptoms remain within normal performance ranges...
Join OARSI PTOA Meeting: Updates & Involvement Opportunities
Join us for the annual @OARSInews PTOA Discussion Group Meeting on Friday 24 April @ #OARSI2026 We will be sharing updates from our PTOA research priority setting, definition & prevalence working groups - lots of opportunities to get involved https://t.co/AlrAwcrhRb
Navy SEAL and Doctor Discuss Stem Cell Breakthroughs
Great podcast with my good friend and Navy Seal William Clark and Dr. Harmon on Stem Cells https://t.co/BDKfPiMHnF
Beyond Rating Scales: AI Brings Natural Language to Depression Screening, Improving Accuracy and User Experience
Researchers at Zhengzhou Normal University introduced BDI‑FS‑GPT, a ChatGPT‑powered interface that embeds the Beck Depression Inventory Fast Screen into a conversational format. In a trial of 115 adults, including 28 diagnosed with depression, the AI tool identified 89.3% of cases...
PainChek Inks Landmark 20,000-Bed North America Deployment with Sabra Health Care REIT
PainChek announced a Master Services Agreement with Sabra Health Care REIT to deploy its pain‑assessment platform across up to 20,000 beds in 329 U.S. and Canadian long‑term‑care facilities. The deal prices the solution at $55‑75 per bed per year under...
Analyst Raises Price Target on UnitedHealth Group (UNH), Keeps ‘Neutral’ Rating
Bank of America analyst Kevin Fischbeck raised UnitedHealth Group’s (UNH) price target from $315 to $337 on April 7, while keeping a neutral rating, suggesting more than 10% upside. The adjustment follows the Centers for Medicare & Medicaid Services’ finalization of...
Federal Judge Dismisses Anthem's No Surprises Act Lawsuit, Delivering Win for 20,000 Providers
A federal magistrate in California dismissed Anthem Blue Cross's lawsuit targeting HaloMD and dozens of California providers, citing a lack of legal basis. The ruling upholds the No Surprises Act’s independent dispute‑resolution mechanism, a safeguard for roughly 30 million patients and...
CDC Pauses Dozens of Types of Lab Testing During Evaluation and in Wake of Downsizing
The Centers for Disease Control and Prevention announced it is pausing more than two dozen diagnostic tests, including rabies and monkeypox, after a sweeping staff reduction. Staffing across the agency fell between 20% and 25% over the past year, with...
An Unlikely New Best Friend and Advocate
Pediatric oncologists treat roughly 15,000‑16,000 U.S. children with cancer each year, a tiny fraction of the 70 million child population but the leading cause of death among kids. Over 100 distinct cancer types affect children, and while 85% of diagnosed patients...
Entropy Neurodynamics' TRP-8803 Trial Shows Repeatable Psychedelic Effects in BED Study
Entropy Neurodynamics (ASX: ENP) reported that the third patient in its TRP‑8803 IV‑infused psilocin trial for binge‑eating disorder completed two doses and exhibited a repeatable psychedelic response. The trial, designed for 12 participants across two cohorts, is nearing the end...
Another QMSR Town Hall – What Changes and What Stays the Same in FDA’s Inspection Process
The FDA held its April 1 QMSR town hall to clarify how inspections will change once the Quality Management System Regulation takes effect on February 2, 2026. Inspectors will evaluate every element of a manufacturer’s QMS, emphasizing risk‑management documentation throughout the system. While...
Vaccinate Anytime: RSV and Measles Protection Still Available
It’s not too late to make sure you are protected against RSV. It's never too late to make sure you are protected against measles. https://t.co/BVayTHRMJz
Ultralight Raises $9.3M to Launch AI-Native Operating System for Healthcare
Ultralight, formerly Vibrant Practice, secured $9.3 million led by The General Partnership to develop an AI‑native operating system tailored for Direct Primary Care. The platform aims to replace fragmented legacy EHRs with a unified, “invisible” infrastructure that reduces clinician charting time....
Biden FDA Knew About COVID Vaccine Stroke Risk and Kept Americans in the Dark
Senate investigators reviewing roughly 2,000 pages of federal records say the FDA and CDC identified a potential ischemic‑stroke risk linked to Pfizer’s bivalent COVID‑19 booster for adults over 65 as early as October 2022. The agencies documented 226 stroke cases...
Crackdown on Vapes Falling Short, Report Finds
A Government Accountability Office report finds the Justice Department’s enforcement of illegal e‑cigarette sales has lagged behind a booming market. From 2022 to 2025, DOJ launched only 88 actions, mainly adding online sellers to a blacklist, while roughly 6,000 vape...
Loss of Smell May Signal Alzheimer’s Years Before Cognitive Decline, Study Finds
Scientists have identified a decline in olfactory ability as a possible early warning sign of Alzheimer’s disease, driven by microglial attacks on smell‑related nerve fibers. The finding could reshape screening strategies and intersect with meditation‑based approaches to brain health.
AI Access to All Data Exposes Waste and Fraud
Profound thought here by @sundeep ⬇️ in a world where AI is a relentless optimizer, waste, excess and fraud will be easily spotted if AI is given access to all of the data and it systems.
Echovision AI Glasses for the Blind and Low Vision Users
AGIGA launched EchoVision, an AI‑powered smart‑glass system aimed at blind and low‑vision users. The sunglasses‑style device uses a Qualcomm Snapdragon processor to provide real‑time audio scene descriptions, OCR reading of printed text, and instant remote assistance through services like Aira...
Robotic Bronchoscopy System Shows 96.7% Tool‑in‑Lesion Rate in New Study
Noah Medical's Galaxy robotic bronchoscopy platform recorded a 96.7% tool‑in‑lesion rate in the MATCH 2 trial of 31 patients with peripheral pulmonary nodules. The study, led by Dr. Amit K. Mahajan, suggests the device could improve early lung‑cancer detection and broaden...
The AI Arms Race: Why PHTI Warns Healthcare ‘Bot Wars’ Are Inflating Medical Costs
The Peterson Health Technology Institute’s new report warns that artificial‑intelligence tools, while easing administrative tasks for individual health systems, are inflating system‑wide costs. AI‑driven prior‑authorization bots generate more submissions and denials, creating a “bot war” that adds $40‑$50 per request...
CMS Proposes 2.4% Medicare Boost for Inpatient Hospitals and Mandatory Joint‑replacement Model
The Centers for Medicare & Medicaid Services (CMS) announced a 2.4% increase in net payment rates for inpatient hospitals in fiscal year 2027, translating to roughly $1.4 billion more for acute‑care facilities. At the same time, CMS floated its first nationwide...
Australia's Digital Health ROI Problem: Why Focusing on Dollars Is Holding Transformation Back
Australia’s digital health agenda is moving beyond pure financial ROI, emphasizing outcomes, patient and clinician experience, and long‑term system sustainability. Recent policies such as Share by Default and the National Digital Health Strategy have turned digital infrastructure into a core...
Ask What Relieves, Not What Inspires, When Burned Out
Burned-out doctors keep chasing "what's my passion?" Wrong question. Chelsea Turgeon says ask "what feels like relief?" Get to baseline first. The vision comes after you can breathe again. What gave you relief? #burnout #medtwitter https://t.co/Zlp0oqd7BR
California Judge Dismisses Elevance’s No Surprises Act Lawsuit Against HaloMD
A California federal judge dismissed Elevance Health’s lawsuit against HaloMD, which alleged a conspiracy to abuse the No Surprises Act’s Independent Dispute Resolution (IDR) process. Anthem Blue Cross claimed HaloMD filed over 1,500 IDR proceedings from January 2024 to August...
‘My Body Feels Like Lead’: Heat Is Making Pregnancy a Nightmare in Karachi
Pregnant women in Karachi are facing severe health threats as summer temperatures regularly top 40 °C with humidity over 70 %. Power outages lasting up to 12 hours leave slum dwellers without fans or air conditioning, intensifying dehydration, urinary‑tract infections, and heat‑related...
RevMed’s Pancreatic Cancer Win Strengthens the Case for Targeting RAS(ON)
RevMed reported a positive Phase 2 trial of its RAS(ON) inhibitor in patients with advanced pancreatic ductal adenocarcinoma, showing a 23% objective response rate and a median progression‑free survival of 5.8 months. The study enrolled 45 heavily pre‑treated patients and...